Pharmacokinetics, Efficacy and Safety of an Octreotide Implant in Patients With Carcinoid Syndrome
| Status: | Archived |
|---|---|
| Conditions: | Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | July 2009 |
| End Date: | February 2011 |
Open Label Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Two Doses of an Octreotide Implant in Patients With Carcinoid Syndrome
Evaluate the pharmacokinetics, safety and efficacy of an octreotide implant for the
treatment of the symptoms of carcinoid syndrome.
This study will evaluate a longer acting octreotide formulation. A subcutaneous implant at
2 doses will be evaluated for pharmacodynamics, efficacy and safety for a period of 9
months.
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials